These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26242858)

  • 1. Can the publication of guidelines change the management of early rheumatoid arthritis? An interrupted time series analysis from the United Kingdom.
    Judge A; Wallace G; Prieto-Alhambra D; Arden NK; Edwards CJ
    Rheumatology (Oxford); 2015 Dec; 54(12):2244-8. PubMed ID: 26242858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Disease-Modifying Antirheumatic Drug Treatment for Patients With Rheumatoid Arthritis in the US During the COVID-19 Pandemic: A Three-Month Observational Study.
    Michaud K; Pedro S; Wipfler K; Agarwal E; Katz P
    Arthritis Care Res (Hoboken); 2021 Sep; 73(9):1322-1331. PubMed ID: 33787086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying factors associated with concordance with the American College of Rheumatology rheumatoid arthritis treatment recommendations.
    Harrold LR; Reed GW; Kremer JM; Curtis JR; Solomon DH; Hochberg MC; Kavanaugh A; Saunders KC; Shan Y; Spruill TM; Pappas DA; Greenberg JD
    Arthritis Res Ther; 2016 Apr; 18():94. PubMed ID: 27118040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database.
    Edwards CJ; Arden NK; Fisher D; Saperia JC; Reading I; Van Staa TP; Cooper C
    Rheumatology (Oxford); 2005 Nov; 44(11):1394-8. PubMed ID: 16030083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the use of disease modifying antirheumatic medications in rheumatoid arthritis, 1980-1995: results from the National Ambulatory Medical Care Surveys.
    Ward MM
    J Rheumatol; 1999 Mar; 26(3):546-50. PubMed ID: 10090160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gap between practice and guidelines in the choice of first-line disease modifying antirheumatic drug in early rheumatoid arthritis: results from the ESPOIR cohort.
    Benhamou M; Rincheval N; Roy C; Foltz V; Rozenberg S; Sibilia J; Schaeverbeke T; Bourgeois P; Ravaud P; Fautrel B
    J Rheumatol; 2009 May; 36(5):934-42. PubMed ID: 19286850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Rheumatoid Arthritis and Drug Dispensing Patterns Among Medicaid and Medicaid-Medicare Dually Eligible Beneficiaries in Puerto Rico.
    Hernández-Muñoz JJ; Wei W; Sierra-Zorita R
    Arthritis Care Res (Hoboken); 2021 Feb; 73(2):199-206. PubMed ID: 32475025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delay in initiation of DMARD or anti-inflammatory therapy in patients newly diagnosed with rheumatoid arthritis: An analysis of United States Military Health System TRICARE beneficiaries.
    Kimsey L; Weissman JS; Patel A; Drew A; Koehlmoos T; Sparks JA
    Semin Arthritis Rheum; 2019 Apr; 48(5):821-827. PubMed ID: 30190154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of the initiation of disease-modifying antirheumatic drugs in incident rheumatoid arthritis: a German perspective based on nationwide ambulatory drug prescription data.
    Steffen A; Holstiege J; Klimke K; Akmatov MK; Bätzing J
    Rheumatol Int; 2018 Nov; 38(11):2111-2120. PubMed ID: 30306254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the American College of Rheumatology treatment recommendations.
    Harrold LR; Harrington JT; Curtis JR; Furst DE; Bentley MJ; Shan Y; Reed G; Kremer J; Greenberg JD
    Arthritis Rheum; 2012 Mar; 64(3):630-8. PubMed ID: 21953645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the pharmacological management of rheumatoid arthritis over two decades.
    Crossfield SSR; Buch MH; Baxter P; Kingsbury SR; Pujades-Rodriguez M; Conaghan PG
    Rheumatology (Oxford); 2021 Sep; 60(9):4141-4151. PubMed ID: 33404652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and Treatment of New-Onset and Established Rheumatoid Arthritis in an Insured US Population.
    Crane MM; Juneja M; Allen J; Kurrasch RH; Chu ME; Quattrocchi E; Manson SC; Chang DJ
    Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1646-55. PubMed ID: 26097059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Half of U.K. patients with rheumatoid arthritis are prescribed oral glucocorticoid therapy in primary care: a retrospective drug utilisation study.
    Black RJ; Joseph RM; Brown B; Movahedi M; Lunt M; Dixon WG
    Arthritis Res Ther; 2015 Dec; 17():375. PubMed ID: 26702817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary patterns of care and disease activity outcome in early rheumatoid arthritis: the ERAN cohort.
    Kiely P; Williams R; Walsh D; Young A;
    Rheumatology (Oxford); 2009 Jan; 48(1):57-60. PubMed ID: 18984608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Population-Based Approach to Reporting System-Level Performance Measures for Rheumatoid Arthritis Care.
    Barber CEH; Marshall DA; Szefer E; Barnabe C; Shiff NJ; Bykerk V; Homik J; Thorne JC; Ahluwalia V; Benseler S; Mosher D; Twilt M; Lacaille D
    Arthritis Care Res (Hoboken); 2021 May; 73(5):640-648. PubMed ID: 32144843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the prevalence and incidence of rheumatoid arthritis in Korea and an analysis of medical care and drug utilization.
    Won S; Cho SK; Kim D; Han M; Lee J; Jang EJ; Sung YK; Bae SC
    Rheumatol Int; 2018 Apr; 38(4):649-656. PubMed ID: 29302803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Strategies in Early Rheumatoid Arthritis Methotrexate Management: Results From a Prospective Cohort.
    Moura CS; Schieir O; Valois MF; Thorne C; Bartlett SJ; Pope JE; Hitchon CA; Boire G; Haraoui B; Hazlewood GS; Keystone EC; Tin D; Bykerk VP; Bernatsky S;
    Arthritis Care Res (Hoboken); 2020 Aug; 72(8):1104-1111. PubMed ID: 31112011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update of French society for rheumatology recommendations for managing rheumatoid arthritis.
    Daien C; Hua C; Gaujoux-Viala C; Cantagrel A; Dubremetz M; Dougados M; Fautrel B; Mariette X; Nayral N; Richez C; Saraux A; Thibaud G; Wendling D; Gossec L; Combe B
    Joint Bone Spine; 2019 Mar; 86(2):135-150. PubMed ID: 30315988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis.
    Jin Y; Desai RJ; Liu J; Choi NK; Kim SC
    Arthritis Res Ther; 2017 Jul; 19(1):159. PubMed ID: 28679392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability in Glucocorticoid Prescribing for Rheumatoid Arthritis and the Influence of Provider Preference on Long-Term Use of Glucocorticoids.
    George MD; Baker JF; Wallace B; Chen L; Wu Q; Xie F; Yun H; Curtis JR
    Arthritis Care Res (Hoboken); 2021 Nov; 73(11):1597-1605. PubMed ID: 32702188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.